Objective: The aim of this study was to evaluate the angiogenicity of a combination of BM-EPCs and BM-MSCs in vitro in the presence of SP and its working mechanism. 
reparative stem or precursor cells for the repair of the BBB following a stroke.
In the BBB of the CNS, the inner endothelial tube is tightly encircled by pericytes, which share a basement membrane with endothelial cells and form direct synaptic-like peg-socket focal contacts between two cell types through N-cadherin and connexins. 3, 4 Thereby, pericytes maintain endothelial tight junctions and regulate the capillary diameter and cerebrovascular flow under physiological conditions.
Notably, close cooperation between brain endothelial cells and pericytes in the BBB has been reported in platelet-derived growth factor (PDGF)-B or PDGFR beta null mice, which results in a complete loss of pericytes, causing the rupture of CNS microvessels, micro-aneurysms, and embryonic lethality. 5, 6 Furthermore, after brain injury, pericytes seem to be more vulnerable than any other cell type in the BBB. [6] [7] [8] [9] A reparative stem cell therapy targeting the replacement and recruitment of both pericytes and endothelial cells is in high demand.
Bone marrow is a reservoir of autologous stem cells such as MSCs, EPCs, and hematopoietic stem cells, which can be harvested from bone marrow aspirates and peripheral blood by the specific stem cell mobilizer. 10 EPCs have been utilized for neovascularization after transplantation post-CNS insult and myocardial infarction. 11, 12 BM-
MSCs have been used in the treatment of a variety of tissue injuries
and diseases because of their capacity to regulate severe immune and inflammatory responses by secreting protective trophic factors. 13, 14 It is also expected that BM-MSCs may play a similar role as pericytes in the blood vessel, based on their similar marker expression patterns and phenotype. 15, 16 However, dual cell therapy with both BM-EPCs and BM-MSCs aimed toward tight blood vessel formation and investigation into their cooperated roles has not been widely studied.
In this study, we first evaluated whether EPCs and MSCs derived from the bone marrow can concertedly work in the reconstruction of a pericyte-covered vascular network, using a Matrigel tubular network assay. Because we are targeting the BBB, which is regarded as the most pericyte-dense area in the body with an endothelial-pericyte ratio between 1:1 and 3:1, in this study, BM-EPCs and BM-MSCs were applied at a ratio of 2:1 by considering of the physiological condition as well as the capability of BM-MSCs on immune modulation. 3 We also evaluated whether the SP/NK-1R signaling pathway, known to be expressed and to activate cell proliferation and migration in both cell types, 17, 18 is involved in the pericyte coverage of the endothelia.
Finally, the important regulators of the endothelial tubular network as well as pericyte-like coverage of the endothelia were investigated.
Using this in vitro coculture system, the feasibility of a dual stem cell therapy in BBB reconstruction after transplantation following ischemic stroke can be pretested. 
| MATERIALS AND METHODS

| Primary culture and identification of rat BMEPCs and BM-MSCs
| Matrigel tube formation
A Matrigel tube formation assay was performed for the in vitro angiogenesis assessment. 20 A 48-well plate was treated with 150 μL of Matrigel (BD Biosciences, San Jose, CA, USA) for 30 minutes at 37°C. 
| Enzyme-linked immunosorbent assay (ELISA)
The culture media were collected from equal cell quantities of BMMSCs, BM-EPCs, or BM-EPC/BM-MSC cocultures at a ratio of 2:1.
VEGF and PDGF-BB levels were measured using VEGF and PDGF-BB ELISA kits (R&D system, Inc., Minneapolis, MN, USA). Data from three independent experiments were statistically analyzed.
| RT-PCR analysis
Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. The template cDNAs were synthesized using a Prime-script RT-PCR kit (Takara Bio. Inc., antisense: AGA AGA GCT ATGA GCT GCC TGA CG).
| Western blotting
The cell lysates were prepared using a Cell Lysis Kit (Cell Signaling, Danvers, Massachusetts, USA) according to the manufacturer's instructions, subjected to separation by 10% SDS-PAGE, and transferred to nitrocellulose membranes. The blots were blocked with 5% The quantification of tube length in the vascular tube structure was measured using Image J. Data are presented as mean ± SEM (**P < .005, ***P < .0005, student's t test) skim milk in PBS. Western blots were then probed with antibodies recognizing N-cadherin (1:300; Abcam). Signals were detected using a Chemilluminator (Vilber Lourmat, Marne, France). Both BM-EPCs and BM-MSCs express SP receptor NK-1R, 22 and SP is known to mobilize BM-MSCs from the bone marrow into the blood and aid in their recruitment to the injured tissue. 19 We explored whether SP treatment can affect the tube-forming capacity of the MSCs and/or EPCs. The SP treatment did not affect MSC behavior but resulted in an approximately 27% increase in EPC tube-forming capacity ( Figure 1A ,B). 
| RESULTS
| BM-EPCs
| BM-
| PDGF-BB blocking reduces BM-MSC coverage of the endothelial tubules
To further confirm the role of PDGF-BB in the pericyte-like cell recruitment of BM-MSCs on the endothelia, PDGF-BB expression was examined in the coculture on Matrigel ( Figure 4A ). The coculture strongly induced PDGF-BB secretion at 3 hours after cell plating, 
| DISCUSSION
Stroke is a common type of vascular occlusion or hemorrhage rupture in the brain. Currently, early resolution of the blood clots within 6 hours after a stroke is the only clinically approved treatment, and a very small portion of patients qualify for such treatment. The characteristics defining EPCs based on origin and markers expression have been debated for years. 19 It was previously claimed that EPCs originate in the peripheral blood rather than the bone marrow. 
| PERSPECTIVE
This study proposes the rationale and working mechanism of dual cell 
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